Raheleh Amirkhah
Raheleh Amirkhah
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
MicroRNA–mRNA interactions in colorectal cancer and their role in tumor progression
R Amirkhah, U Schmitz, M Linnebacher, O Wolkenhauer, A Farazmand
Genes, Chromosomes and Cancer 54 (3), 129-141, 2015
Exosomal lncRNAs and cancer: connecting the missing links
H Naderi-Meshkin, X Lai, R Amirkhah, J Vera, JEJ Rasko, U Schmitz
Bioinformatics 35 (2), 352-360, 2019
Cancer statistics in Iran: Towards finding priority for prevention and treatment
R Amirkhah, H Naderi-Meshkin, M Mirahmadi, A Allahyari, HR Sharifi
cancerpress, 2017
The intricate interplay between epigenetic events, alternative splicing and noncoding RNA deregulation in colorectal cancer
R Amirkhah, H Naderi-Meshkin, JS Shah, PD Dunne, U Schmitz
Cells 8 (8), 929, 2019
Naïve Bayes classifier predicts functional microRNA target interactions in colorectal cancer
R Amirkhah, A Farazmand, SK Gupta, H Ahmadi, O Wolkenhauer, ...
Molecular bioSystems 11 (8), 2126-2134, 2015
The role of microRNAs in the resistance to colorectal cancer treatments
R Amirkhah, A Farazmand, M Irfan-Maqsood, O Wolkenhauer, U Schmitz
Cellular and Molecular Biology 61 (6), 17-23, 2015
In-depth clinical and biological exploration of DNA damage immune response as a biomarker for oxaliplatin use in colorectal cancer
SB Malla, DJ Fisher, E Domingo, A Blake, S Hassanieh, KL Redmond, ...
Clinical Cancer Research 27 (1), 288-300, 2021
Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data
NC Fisher, R Byrne, H Leslie, C Wood, A Legrini, A Cameron, ...
Clin Cancer Res, 4056-4069, 2022
MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer
R Amirkhah, K Gilroy, SB Malla, TRM Lannagan, RM Byrne, NC Fisher, ...
British Journal of Cancer 128 (7), 1333-1343, 2023
Downregulation of PPARα during experimental left ventricular hypertrophy is critically dependent on Nox2 NADPH oxidase signalling
AP Harvey, E Robinson, KS Edgar, R McMullan, KM O’Neill, M Alderdice, ...
International journal of molecular sciences 21 (12), 4406, 2020
Computational and experimental identification of Tissue-Specific MicroRNA targets
R Amirkhah, HN Meshkin, A Farazmand, JEJ Rasko, U Schmitz
MicroRNA Detection and Target Identification: Methods and Protocols, 127-147, 2017
Activation of innate-adaptive immune machinery by poly (I: C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer
SM Corry, AMB McCorry, TRM Lannagan, NA Leonard, NC Fisher, ...
Gut 71 (12), 2502-2517, 2022
Critical issues in successful production of skin substitutes for wound healing
H Naderi-Meshkin, R Amirkhah, A Heirani-Tabasi, MI Maqsood
Journal of Genes and Cells 4 (1), 10-32, 2018
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer
SB Malla, RM Byrne, MW Lafarge, SM Corry, NC Fisher, PK Tsantoulis, ...
Nature Genetics, 1-15, 2024
Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data
B Ahmaderaghi, R Amirkhah, J Jackson, TRM Lannagan, K Gilroy, ...
Disease Models & Mechanisms 15 (3), dmm049257, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
DJ Flanagan, R Amirkhah, DF Vincent, N Gunduz, P Gentaz, ...
Nature Communications 13 (1), 7551, 2022
Engineered Cell Therapy: A Successful Approach to Treat Cancer
M Irfan-maqsood, M Bahrami, R Amirkhah, H Naderi-meshkin
Genes and Cells 1, 1.82, 2015
Improvement of bladder cancer immunotherapy by creating a recombinant Bacille Calmette-Gu'erin which secrets p53 protein.
R Amirkhah, H Khanahmad, M Abolhassani, M Pooya, H Movassagh, ...
Medical hypotheses 72 (6), 754-754, 2009
Adoptive Cell Transfer to Enhance Patients Immunity Against Cancer
M Irfan-Maqsood, M Bahrami, R Amirkhah
Journal of Genes and Cells 1 (3), 67, 2015
Pathway level subtyping identifies a slow-cycling and transcriptionally lethargic biological phenotype associated with poor clinical outcomes in colon cancer independent of …
SB Malla, RM Byrne, M Lafarge, SM Corry, NC Fisher, P Tsantoulis, ...
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20